Vanda Pharmaceuticals Inc - Company Profile
Powered by 
All the sales intelligence you need on Vanda Pharmaceuticals Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Vanda Pharmaceuticals Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Vanda Pharmaceuticals Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Vanda Pharmaceuticals Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20230073637A1 | Application | TREATMENT OF ATOPIC DERMATITIS WITH TRADIPITANT | A61K31/444; C12Q1/6883; C12Q2600/106; C12Q2600/156 | March 09, 2023 |
| AU2021273588B2 | Grant | MELATONIN AGONIST TREATMENT | A61K31/343; A61K31/405; A61K9/0053; A61P25/00; A61P25/20; A61P43/00; A61P5/04 | March 02, 2023 |
| WO2023288240A9 | Search Report | ANTISENSE OLIGONUCLEOTIDE (ASO) GENE INHIBITION AND TREATMENT | A61K31/7088; A61P19/00; A61P21/00; C12N15/1137; C12N2310/11; C12N2320/30; C12N2320/34 | February 23, 2023 |
| EP4137129A1 | Application | TASIMELTEON ZUR BEHANDLUNG DES SMITH-MAGENIS-SYNDROMS | A61K2300/00; A61K31/00; A61K31/343; A61K45/06; A61P25/20; A61P43/00 | February 22, 2023 |
| WO2023019084A1 | Application | TREATMENT OF GASTRIC ACCOMMODATION WITH TRADIPITANT | A61K31/4439; A61P1/00; A61P1/08; A61P1/14 | February 16, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer